Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Melanoma
×
lenvatinib
×
90 days
×
Clear all
Filters
3
NCT04305054
2026-04-08
KEYMAKER-U02
Merck Sharp & Dohme LLC
Phase 1/2
Active not recruiting
315 enrolled
NCT03820986
2026-02-09
LEAP-003
Merck Sharp & Dohme LLC
Phase 3
Completed
674 enrolled
21 charts